PUTRAJAYA: The AstraZeneca COVID-19 vaccine is safe for use in Malaysia, said Health Minister Datuk Seri Dr Adham Baba.
He said the AstraZeneca COVID-19 vaccine safety data, obtained from clinical studies as of Nov 4, 2020 involving 12,000 volunteers, showed that no serious side effects were reported.
The usual side effects frequently reported were soreness at the site of inoculation, lethargy, headaches, and others classified as mild or moderate onsets.
"Data also showed that post-vaccination effects were significantly reduced after the second dose was administered," he said in a statement regarding the safety status of the AstraZeneca COVID-19 vaccine, which was approved for registration by the Drug Control Authority (DCA) on March 2.
According to him the clinical studies also concluded that there were no safety issues concerning its effects on the blood's profile and contents, including blood clotting, after receiving the vaccine jab.
Dr Adham said AstraZeneca Sdn Bhd had also held a meeting with the National Pharmaceutical Regulatory Division (NPRA) on March 17 to explain the actual situation regarding the safety issue of the AstraZeneca COVID-19 vaccine, especially relating to blood clots (thromboembolic events).
According to the company, a total of 17 million people had received the AstraZeneca COVID-19 vaccine in the European Union (EU) and the United Kingdom (UK) as of March 8, with 15 cases of deep vein thrombosis (DVT) and 22 cases of pulmonary embolism reported from among the recipients.
Dr Adham said the company had conducted detailed studies of all the cases and concluded that there was no solid evidence that could link the vaccine to the risk of thromboembolic events.
"The total number of thromboembolic event cases reported was also far lower compared to the average expected cases in that population size and the conclusion was also supported by the European Medicines Agency (EMA).
"Therefore, it is concluded that the AstraZeneca COVID-19 vaccine is safe for use," he said.
Dr Adham said the Ministry of Health was committed to carrying out continuous monitoring to ensure the quality, safety and effectiveness of the COVID-19 vaccines are always guaranteed.
Recipients can report adverse effects following COVID-19 vaccine jabs through health personnel, directly to the NPRA website at www.npra.gov.my or through the MySejahtera application for mild adverse effects, he said.
On March 15, National COVID-19 Immunisation Programme Coordinating Minister Khairy Jamaluddin said Malaysia would proceed with the purchase and acquisition of AstraZeneca COVID-19 vaccines as there has been no evidence that the vaccine causes blood clots.
The Science, Technology and Innovation Minister said AstraZeneca had informed Malaysia on the side effects of the vaccine and so far, there has been no data to indicate any direct link between the vaccine and reports of blood clots in people, which had resulted in deaths in a few countries.
Several countries such as Denmark, Norway, Iceland and Thailand have reportedly paused the rollout of AstraZeneca's vaccine following reports of blood clots occurring in several individuals after being vaccinated.
-- BERNAMA
Bernama
Wed Mar 24 2021
Several countries such as Denmark, Norway, Iceland and Thailand have reportedly paused the rollout of AstraZeneca's vaccine following reports of blood clots occurring in several individuals after being vaccinated. - Reuters
MAA semak semula unjuran jualan kenderaan 2024 kepada 765,000 unit
Persatuan Automotif Malaysia (MAA) telah menyemak semula unjuran jualan kenderaan bermotor baharu bagi 2024 kepada 765,000 unit daripada anggaran sebelumnya sebanyak 740,000 unit.
RUU 355: Pindaan perlu untuk praktikaliti, keadilan
Apa sahaja pindaan terhadap akta itu perlu berjalan selari dengan persediaan mereka yang bertanggungjawab melaksanakannya.
Rasionalisasi RON95 dijangka beri impak lebih besar kepada PKS - SAMENTA
SAMENTA menjangkakan rasionalisasi RON95 akan memberi impak yang lebih besar kepada perusahaan kecil dan sederhana (PKS) berbanding pelarasan subsidi diesel.
Malaysia sasar pengeluaran 40 peratus sektor akuakultur menjelang 2030
Malaysia menyasarkan pengeluaran 40 peratus hasil sektor akuakultur menjelang 2030 dalam usaha membantu mengimbangi keperluan perikanan negara.
10 Berita Pilihan - (16 Julai 2024
Antara pelbagai berita dalam dan luar negara yang disiarkan di Astro AWANI, berikut adalah yang paling menjadi tumpuan sepanjang hari ini.
PAC beri tempoh tiga bulan kepada HRD Corp
Jawatankuasa Kira-kira Wang Negara (PAC) memberi tempoh tiga bulan kepada Perbadanan Pembangunan Sumber Manusia (HRD Corp) untuk mengemukakan laporan tindakan susulan terhadap syor jawatankuasa itu.
Kylian Mbappe tandatangan kontrak dengan Real Madrid
Bintang bola sepak Perancis Kylian Mbappe menandatangani kontrak selama lima tahun dengan kelab Sepanyol Real Madrid pada Selasa.
Pelepasan ketujuh air sisa nuklear Fukushima ke laut selesai
Jepun telah menyelesaikan pusingan ketujuh pelepasan air sisa radioaktif yang dirawat dari loji kuasa nuklear Fukushima Daiichi ke Lautan Pasifik pada Selasa.
Empat termasuk kapten maut dalam pertempuran
Empat anggota tentera India termasuk kapten meninggal dunia akibat kecederaan selepas pertempuuran pada malam isnin di Hutan Desa.
Pakistan sahkan 4 warganya terbunuh di Oman
Pakistan berkata pada Selasa empat warganya terbunuh dalam insiden tembakan pada malam Isnin berhampiran ibu negara Oman, Muscat.
PAC: Perolehan ventilator ketika Dr Adham Baba jadi Menteri Kesihatan - Mas Ermieyati
Perolehan ventilator tanpa perjanjian bertulis seperti dalam laporan Jawatankuasa Kira-Kira Wang Negara (PAC) sebelum ini berlaku ketika Dr Adham Baba menjadi Menteri Kesihatan.
Tindakan bawa Ketua Cawangan pergi bercuti tidak perlu dipertikaikan - Hasrul
Khidmat mereka ini adalah secara sukarelawan dan bukannya mendapat gaji tetap setiap bulan, jelas Hasrul
PRU15: UMNO yakin kekal tiga kerusi deposit di Johor - Dr Adham
Kerusi Parlimen Tenggara, Kota Tinggi dan Pengerang, yang merupakan kawasan deposit tetap UMNO diyakini kekal dalam genggaman Barisan Nasional (BN) pada Pilihan Raya Umum ke-15 (PRU15).
PRU15: 'Saya orang parti, penting untuk sokong calon baharu' - Dr Adham Baba
Jelas Dr Adham, sebagai orang parti, adalah penting untuk pemimpin menyokong calon muka baharu dalam memastikan kemenangan BN.
PRU15: Dr Adham gugur, BN calonkan Manndzri Nasib di Parlimen Tenggara
Datuk Seri Dr Adham Baba tidak diumumkan sebagai calon yang bakal bertanding untuk mempertahankan kerusi itu pada Pilihan Raya Umum ke-15 (PRU15).
Calon PRU15: "Tak letak Dr Adham di Tenggara satu malapetaka besar" - Nasaruddin
Barisan Nasional (BN) Tenggara memohon agar pucuk pimpinan parti itu mengekalkan penyandang kerusi Parlimen Tenggara, Datuk Seri Dr Adham Baba untuk bertanding di kawasan itu.
PRU15: BN Johor umum manifesto, lancar jentera parti 2 November
BN Johor akan bentang manifesto serta perkembangan Ikhtiar Johor seperti yang telah dibentangkan pada PRN Johor yang lalu.
MOSTI mahu pendekatan lebih kreatif digunakan dalam pembelajaran STEM
Pendekatan yang lebih kreatif dan inovatif amat digalakkan dalam pembelajaran subjek Sains, Teknologi, Kejuruteraan dan Matematik (STEM).
Usahawan Pahang disaran sertai program MYStartup
Bilangan syarikat pemula di Pahang yang berdaftar masih berada pada tahap yang rendah iaitu hanya 13 syarikat daripada sektor edutech, agritech, e-dagang, logistik dan kesihatan.
Malaysia, IAEA tandatangani perjanjian kerjasama
Bidang kerjasama antara kedua-dua pihak dalam aspek pendidikan dan latihan bagi keselamatan radiasi, pengangkutan dan sisa.